Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy

References

• Bulik M, Jancalek R, Vanicek J, Skoch A, Mechl M. Potential of MR spectroscopy for assessment of glioma grading. Clin Neurol Neurosurg 2013;115:146–53.
   PubMed Web of Science ®Google Scholar
• Callot V, Galanaud D, Le Fur Y, et al. (1)H MR spectroscopy of human brain tumours: a practical approach. Eur J Radiol 2008;67:268–74.
   PubMed Web of Science ®Google Scholar
• Galanaud D, Chinot O, Nicoli F, et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 2003;98:269–76.
   PubMed Web of Science ®Google Scholar
• Horska A, Barker PB. Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am 2010;20: 293–310.
   PubMed Web of Science ®Google Scholar
• Lai PH, Ho JT, Chen WL, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. Am J Neuroradiol 2002;23:1369–77.
   PubMed Web of Science ®Google Scholar
• Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002;52:316–24.
   PubMed Web of Science ®Google Scholar
• Stupp R, Tonn JC, Brada M, Pentheroudakis G, Group EGW. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21: v190–3.
   PubMed Web of Science ®Google Scholar
• Venkatesh SK, Gupta RK, Pal L, Husain N, Husain M. Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain. J Magn Reson Imaging 2001;14:8–15.
   PubMed Web of Science ®Google Scholar
• Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44: 371–81.
   PubMed Web of Science ®Google Scholar
• Yamasaki F, Takaba J, Ohtaki M, et al. Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy. Neurosurg Rev 2005;28:267–77.
   PubMed Web of Science ®Google Scholar
• McKnight TR, Lamborn KR, Love TD, et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 2007;106:660–6.
   PubMed Web of Science ®Google Scholar
• Meyerand ME, Pipas JM, Mamourian A, Tosteson TD, Dunn JF. Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. Am J neuroradiol 1999;20:117–23.
   PubMed Web of Science ®Google Scholar
• Stadlbauer A, Gruber S, Nimsky C, et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006;238:958–69.
   PubMed Web of Science ®Google Scholar
• Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–9.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223–32.
   PubMed Web of Science ®Google Scholar
• Pamir MN, Ozduman K, Yildiz E, Sav A, Dincer A. Intraoperative magnetic resonance spectroscopy for identification of residual tumor during low-grade glioma surgery. J Neurosurg 2013; 118:1191–8.
   PubMed Web of Science ®Google Scholar
• Hattingen E, Delic O, Franz K, et al. (1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas. Neurol Res 2010;32:593–602.
   PubMed Web of Science ®Google Scholar
• Nafe R, Herminghaus S, Raab P, et al. Preoperative proton- MR spectroscopy of gliomas–correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol 2003; 63:233–45.
   PubMed Web of Science ®Google Scholar
• Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44:656–66.
   PubMed Web of Science ®Google Scholar
• Woodworth G, McGirt MJ, Samdani A, et al. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res 2005;27:358–62.
   PubMed Web of Science ®Google Scholar
• Chernov MF, Muragaki Y, Ochiai T, et al. Spectroscopy- supported frame-based image-guided stereotactic biopsy of parenchymal brain lesions: comparative evaluation of diagnostic yield and diagnostic accuracy. Clin Neurol Neurosurg 2009;111: 527–35.
   PubMed Web of Science ®Google Scholar
• Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003;24:1989–98.
   PubMed Web of Science ®Google Scholar